Clinical utility of combined T2-weighted imaging and T2-mapping in the detection of prostate cancer: a multi-observer study.
Prostate
T2-mapping
magnetic resonance imaging (MRI)
Journal
Quantitative imaging in medicine and surgery
ISSN: 2223-4292
Titre abrégé: Quant Imaging Med Surg
Pays: China
ID NLM: 101577942
Informations de publication
Date de publication:
Sep 2020
Sep 2020
Historique:
entrez:
4
9
2020
pubmed:
4
9
2020
medline:
4
9
2020
Statut:
ppublish
Résumé
To evaluate the clinical utility of combined T2-weighted imaging and T2-mapping for the detection of prostate cancer. Forty patients underwent multiparametric magnetic resonance imaging (mpMRI) and T2-mapping of the prostate. Three readers each reviewed two sets of images: T2-weighted fast spin-echo (FSE) sequence (standard T2), and standard T2 in combination with T2-mapping. Each reader assigned probability scores for malignancy to each zone [peripheral zone (PZ) or transition zone (TZ)]. Inter-observer variability for standard T2 and combined standard T2 with T2-mapping were assessed. Diagnostic accuracy was compared between standard T2 and combined standard T2 with T2-mapping. There was fair agreement between all three readers for standard T2 [intraclass correlation coefficient (ICC) =0.56] and combined standard T2 with T2-mapping (ICC =0.58). There was no significant difference in the area under the receiver operator characteristics curve for standard T2 compared to combined standard T2 with T2-mapping (0.89 Combination of T2-weighted imaging and T2-mapping could potentially increase Sn for prostate malignancy compared to T2-weighted imaging alone.
Sections du résumé
BACKGROUND
BACKGROUND
To evaluate the clinical utility of combined T2-weighted imaging and T2-mapping for the detection of prostate cancer.
METHODS
METHODS
Forty patients underwent multiparametric magnetic resonance imaging (mpMRI) and T2-mapping of the prostate. Three readers each reviewed two sets of images: T2-weighted fast spin-echo (FSE) sequence (standard T2), and standard T2 in combination with T2-mapping. Each reader assigned probability scores for malignancy to each zone [peripheral zone (PZ) or transition zone (TZ)]. Inter-observer variability for standard T2 and combined standard T2 with T2-mapping were assessed. Diagnostic accuracy was compared between standard T2 and combined standard T2 with T2-mapping.
RESULTS
RESULTS
There was fair agreement between all three readers for standard T2 [intraclass correlation coefficient (ICC) =0.56] and combined standard T2 with T2-mapping (ICC =0.58). There was no significant difference in the area under the receiver operator characteristics curve for standard T2 compared to combined standard T2 with T2-mapping (0.89
CONCLUSIONS
CONCLUSIONS
Combination of T2-weighted imaging and T2-mapping could potentially increase Sn for prostate malignancy compared to T2-weighted imaging alone.
Identifiants
pubmed: 32879859
doi: 10.21037/qims-20-222
pii: qims-10-09-1811
pmc: PMC7417765
doi:
Types de publication
Journal Article
Langues
eng
Pagination
1811-1822Informations de copyright
2020 Quantitative Imaging in Medicine and Surgery. All rights reserved.
Déclaration de conflit d'intérêts
Conflicts of Interest: All authors have completed the ICMJE uniform disclosure form (available at http://dx.doi.org/10.21037/qims-20-222). CHL reports grants and non-financial support from Siemens Healthineers, during the conduct of the study. MT reports grants and non-financial support from Siemens Healthineers, during the conduct of the study; grants and personal fees from CRC 1340/1 (DFG, Germany Research Foundation), outside the submitted work. PA reports grants and non-financial support from Siemens Healthineers, during the conduct of the study; personal fees from b.e.imaging, grants from CRC 1340/1 (DFG, Germany Research Foundation), other from ESR European Society of Radiology, other from DRG Germany Roentgen Society, personal fees and other from CSR Chinese Society of Radiology, outside the submitted work. MH reports grants and non-financial support from Siemens Healthineers, during the conduct of the study; personal fees from b.e.imaging, outside the submitted work. The other author has no conflicts of interest to declare.
Références
J Magn Reson Imaging. 2015 Oct;42(4):1072-7
pubmed: 25704897
Magn Reson Med. 2011 May;65(5):1400-6
pubmed: 21394778
Radiology. 2010 May;255(2):485-94
pubmed: 20413761
Magn Reson Med. 2016 Dec;76(6):1720-1729
pubmed: 26765746
Eur Urol. 2014 Jul;66(1):22-9
pubmed: 24666839
AJR Am J Roentgenol. 2012 Oct;199(4):830-7
pubmed: 22997375
J Magn Reson Imaging. 2011 Aug;34(2):420-8
pubmed: 21780234
J Magn Reson Imaging. 2014 Sep;40(3):723-9
pubmed: 24924835
Eur Urol. 2016 Jan;69(1):16-40
pubmed: 26427566
J Magn Reson Imaging. 2013 May;37(5):1035-54
pubmed: 23606141
Prostate. 2013 Apr;73(5):467-75
pubmed: 22996830
Magn Reson Med. 2018 Mar;79(3):1586-1594
pubmed: 28671331
Acad Radiol. 2019 Jan;26(1):15-21
pubmed: 29731420
Lancet. 2017 Feb 25;389(10071):815-822
pubmed: 28110982
Magn Reson Imaging. 2015 Jun;33(5):525-30
pubmed: 25687187
Magn Reson Med. 2001 Dec;46(6):1054-8
pubmed: 11746568
Radiographics. 2016 Sep-Oct;36(5):1354-72
pubmed: 27471952
Phys Med Biol. 2016 Aug 7;61(15):5587-605
pubmed: 27384985
Eur Radiol. 2012 Apr;22(4):746-57
pubmed: 22322308
Acta Radiol. 2017 Jan;58(1):114-120
pubmed: 26917785
Radiology. 2016 Jun;279(3):805-16
pubmed: 26761720
Magn Reson Med. 2010 Oct;64(4):1155-61
pubmed: 20564590
J Magn Reson Imaging. 2018 Jun;47(6):1646-1653
pubmed: 29135073
Acad Radiol. 2019 Jan;26(1):5-14
pubmed: 29705281
BJU Int. 2011 Oct;108(8 Pt 2):E171-8
pubmed: 21426475
Clin Cancer Res. 2017 Jul 15;23(14):3692-3699
pubmed: 28143868
Eur J Radiol. 2012 Mar;81(3):456-60
pubmed: 21354732
Diagn Interv Imaging. 2015 Apr;96(4):365-72
pubmed: 25547670
Radiology. 2010 Mar;254(3):818-26
pubmed: 20123898
AJR Am J Roentgenol. 2012 Oct;199(4):822-9
pubmed: 22997374
Acad Radiol. 2015 Nov;22(11):1409-18
pubmed: 26343218
AJR Am J Roentgenol. 2012 Oct;199(4):W496-500
pubmed: 22997399
Eur Urol. 2016 Jan;69(1):149-56
pubmed: 25862143
Korean J Radiol. 2017 Jan-Feb;18(1):113-131
pubmed: 28096723
BJU Int. 2013 Nov;112 Suppl 2:6-20
pubmed: 24127671
Abdom Imaging. 2015 Jan;40(1):134-42
pubmed: 25034558
Urology. 2011 May;77(5):1148-52
pubmed: 21334045
Radiology. 2017 Aug;284(2):451-459
pubmed: 28394754
N Engl J Med. 2018 May 10;378(19):1767-1777
pubmed: 29552975
Clin Radiol. 2013 Jun;68(6):e323-30
pubmed: 23528164
Curr Urol. 2015 Jul;8(2):96-100
pubmed: 26889125
Eur J Radiol. 2011 Aug;79(2):172-6
pubmed: 20138721
Infect Agent Cancer. 2017 Oct 30;12:57
pubmed: 29093748